Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal Hyperplasia
Clinical trial NCT04045145 · COMPLETED
Trial details
- NCT number
- NCT04045145
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-12
- Primary completion
- 2021-07-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.